Terpenoid ID | TKC112754 | |
Chirality | TKC206757 | |
Cell line | 0 | |
Protein target | 21 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 43 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC112754 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 100000.0 | nM | GI50 | C105555 | |
TKC112754 | J774.A1 | J-774A.1; J774.A1; J774 A1; J774A.1; J 774A.1; J774 A.1 | 141.0 | nM | IC50 | C134780 | |
TKC112754 | MCF7 | 20000.0 | nM | IC50 | C4194 | ||
TKC112754 | SN12C | SN-12C | 100000.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112754 | MDA-N | MDAN | 100000.0 | nM | GI50 | C3802 | |
TKC112754 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 100000.0 | nM | GI50 | C3512 | |
TKC112754 | ACHN | 100000.0 | nM | GI50 | C6975 | Orphanet_319298 | |
TKC112754 | UO-31 | UO.31; UO31; U031 | 100000.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112754 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 100000.0 | nM | GI50 | C4863 | |
TKC112754 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 100000.0 | nM | GI50 | C3796 | Orphanet_251576 |
TKC112754 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 100000.0 | nM | GI50 | C3224 | |
TKC112754 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 100000.0 | nM | GI50 | C3510 | |
TKC112754 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 100000.0 | nM | GI50 | C105555 | |
TKC112754 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 100000.0 | nM | GI50 | C9142 | Orphanet_99861 |
TKC112754 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 100000.0 | nM | GI50 | C105555 | |
TKC112754 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 100000.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC112754 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 100000.0 | nM | GI50 | C105555 | |
TKC112754 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 100000.0 | nM | GI50 | C105555 | |
TKC112754 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 100000.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC112754 | TK-10 | TK.10; TK 10; TK10 | 100000.0 | nM | GI50 | C4033 | Orphanet_319276 |
TKC112754 | SR | SR-786; SR786 | 100000.0 | nM | GI50 | C37193 | Orphanet_300895 |
TKC112754 | SW-620 | SW-620; SW 620; SW.620 | 100000.0 | nM | GI50 | C4349 | |
TKC112754 | KM12 | KM-12; KM.12 | 100000.0 | nM | GI50 | C4910 | |
TKC112754 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 100000.0 | nM | GI50 | C3512 | |
TKC112754 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 100000.0 | nM | GI50 | C3802 | |
TKC112754 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 100000.0 | nM | GI50 | C3242 | Orphanet_29073 |
TKC112754 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 100000.0 | nM | GI50 | C3802 | |
TKC112754 | BT-549 | BT 549; BT.549; BT549 | 100000.0 | nM | GI50 | C4194 | |
TKC112754 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 100000.0 | nM | GI50 | C3224 | |
TKC112754 | A549 | 20000.0 | nM | IC50 | C3512 | ||
TKC112754 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 100000.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC112754 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 100000.0 | nM | GI50 | C4349 | |
TKC112754 | HCT-15 | HCT-15; HCT.15; HCT15 | 100000.0 | nM | GI50 | C4349 | |
TKC112754 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 100000.0 | nM | GI50 | C4910 | |
TKC112754 | SF-268 | SF-268; SF.268; SF 268 | 100000.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC112754 | EKVX | 75162.0 | nM | GI50 | C3512 | ||
TKC112754 | PC-3 | PC3; PC.3 | 100000.0 | nM | GI50 | C4863 | |
TKC112754 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 100000.0 | nM | GI50 | C7978 | |
TKC112754 | T47D | 2550.0 | nM | IC50 | C4194 | ||
TKC112754 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 100000.0 | nM | GI50 | C3224 | |
TKC112754 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 100000.0 | nM | GI50 | C3224 | |
TKC112754 | MDA-MB-435 | MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 | 100000.0 | nM | GI50 | C3802 | |
TKC112754 | SF-295 | SF-295; SF.295; SF 295 | 100000.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC112754 | Hs-578T | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells | 45604.0 | nM | GI50 | C4194 | |
TKC112754 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 100000.0 | nM | GI50 | C3224 | |
TKC112754 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 100000.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112754 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 100000.0 | nM | GI50 | C45662 | Orphanet_50251 |
TKC112754 | HT-29 | HT 29; HT29 | 50000.0 | nM | IC50 | C4349 | |
TKC112754 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 100000.0 | nM | GI50 | C3510 | |
TKC112754 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 100000.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112754 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 100000.0 | nM | GI50 | C4349 | |
TKC112754 | Jurkat | JURKAT; JM; JM-Jurkat; Jurkat-FHCRC; Jurkat FHCRC; FHCRC-11; FHCRC subclone 11; FCCH1024 | 46500.0 | nM | IC50 | C7953 | Orphanet_99861 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC112754 | P11473 | Vitamin D3 receptor | VDR | 79433 | nM | Potency |
TKC112754 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 9200 | nM | Potency |
TKC112754 | P08684 | Cytochrome P450 3A4 | CYP3A4 | 15849 | nM | Potency |
TKC112754 | P15207 | Androgen receptor | Ar | 29512 | nM | IC50 |
TKC112754 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 794 | nM | Potency |
TKC112754 | P37840 | Alpha-synuclein | SNCA | 2239 | nM | Potency |
TKC112754 | O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | USP1 | 89125 | nM | Potency |
TKC112754 | Q13148 | TAR DNA-binding protein 43 | TARDBP | 15849 | nM | Potency |
TKC112754 | P0DTD1 | Replicase polyprotein 1ab | rep | 7 | % | Inhibition |
TKC112754 | P83916 | Chromobox protein homolog 1 | CBX1 | 100000 | nM | Potency |
TKC112754 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 22 | nM | Potency |
TKC112754 | Q01453 | Peripheral myelin protein 22 | PMP22 | 95283 | nM | Potency |
TKC112754 | O00255 | Menin | MEN1 | 39811 | nM | Potency |
TKC112754 | P02545 | Prelamin-A/C | LMNA | 35481 | nM | Potency |
TKC112754 | Q194T2 | Non-structural protein 1 | NS1 | 14125 | nM | Potency |
TKC112754 | P22310 | UDP-glucuronosyltransferase 1A4 | UGT1A4 | 34 | pm/min/mg | Activity |
TKC112754 | P54855 | UDP-glucuronosyltransferase 2B15 | UGT2B15 | 0 | pm/min/mg | Activity |
TKC112754 | P25094 | Peripheral myelin protein 22 | Pmp22 | 40533 | nM | Potency |
TKC112754 | O35627 | Nuclear receptor subfamily 1 group I member 3 | Nr1i3 | 71 | % | Remaining activity |
TKC112754 | P04278 | Sex hormone-binding globulin | SHBG | 14 | nM | Kd |
TKC112754 | P08185 | Corticosteroid-binding globulin | SERPINA6 | 10000 | nM | Ki |
TKC112754 | P56937 | 3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 | HSD17B7 | 6 | % | Inhibition |
TKC112754 | Q8TDU6 | G-protein coupled bile acid receptor 1 | GPBAR1 | 3330 | nM | EC50 |
TKC112754 | P11413 | Glucose-6-phosphate 1-dehydrogenase | G6PD | 6200 | nM | Ki |
TKC112754 | P11413 | Glucose-6-phosphate 1-dehydrogenase | G6PD | 24900 | nM | IC50 |
TKC112754 | O75795 | UDP-glucuronosyltransferase 2B17 | UGT2B17 | 0 | pm/min/mg | Activity |
TKC112754 | Q9GRG7 | Glucose-6-phosphate 1-dehydrogenase | g6pd | 1100 | nM | Ki |
TKC112754 | Q9UHC9 | NPC1-like intracellular cholesterol transporter 1 | NPC1L1 | >10000 | nM | EC50 |
TKC112754 | Q9Y6A2 | Cholesterol 24-hydroxylase | CYP46A1 | 56 | % | Activity |
TKC112754 | P05804 | Beta-glucuronidase | uidA | 77900 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
P08684 | CP3A4_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 | CP3A4_HUMAN | Atopic eczema [ICD-11: EA80] |
P08684 | CP3A4_HUMAN | Anxiety disorder [ICD-11: 6B00-6B0Z] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P37840 | SYUA_HUMAN | Parkinsonism [ICD-11: 8A00] |
P37840 | SYUA_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P37840 | SYUA_HUMAN | Autonomic nervous system disorder [ICD-11: 8D87] |
O94782 | UBP1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q13148 | TADBP_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 | TADBP_HUMAN | Alzheimer disease [ICD-11: 8A20] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08185 | CBG_HUMAN | Asthma [ICD-11: CA23] |
P08185 | CBG_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P08185 | CBG_HUMAN | Respiratory system disease [ICD-11: CB40-CB7Z] |
P08185 | CBG_HUMAN | Retinopathy [ICD-11: 9B71] |
Q8TDU6 | GPBAR_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 | GPBAR_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 | GPBAR_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
P11413 | G6PD_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P11413 | G6PD_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P11413 | G6PD_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P11413 | G6PD_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P11413 | G6PD_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P11413 | G6PD_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
Q9UHC9 | NPCL1_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q9Y6A2 | CP46A_HUMAN | Acidosis [ICD-11: 5C73] |
Q9Y6A2 | CP46A_HUMAN | Epilepsy/seizure [ICD-11: 8A61-8A6Z] |
Q9Y6A2 | CP46A_HUMAN | Epileptic encephalopathy [ICD-11: 8A62] |
Q9Y6A2 | CP46A_HUMAN | Phakomatoses/hamartoneoplastic syndrome [ICD-11: LD2D] |
Q9Y6A2 | CP46A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05804 | BGLR_ECOLI | Therapeutic intestinal toxicity [ICD-11: DA94] |